Ail, D; Rüfenacht, V; Caprara, C; Samardzija, M; Kast, B; Grimm, C (2015). Increased expression of the proton-sensing G protein-coupled receptor Gpr65 during retinal degeneration. Neuroscience, 301:496-507.
Samardzija, M; Caprara, C; Heynen, S R; Willcox DeParis, S; Meneau, I; Traber, G; Agca, C; von Lintig, J; Grimm, C (2014). A mouse model for studying cone photoreceptor pathologies. Investigative Ophthalmology & Visual Science [IOVS], 55(5):5304-5313.
Caprara, C; Britschgi, C; Samardzija, M; Grimm, C (2014). The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery. Molecular Vision, 20:307-324.
Heynen, S R; Meneau, I; Caprara, C; Samardzija, M; Imsand, C; Levine, E M; Grimm, C (2013). CDC42 is required for tissue lamination and cell survival in the mouse retina. PLoS ONE, 8(1):e53806.
Caprara, C; Grimm, C (2012). From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease. Progress in Retinal and Eye Research, 31(1):89-119.
DeParis, S W; Caprara, C; Grimm, C (2012). Intrinsically photosensitive retinal ganglion cells are resistant to N-methyl-D-aspartic acid excitotoxicity. Molecular Vision, 18:2814-2827.
Lange, C; Caprara, C; Tanimoto, N; Beck, S; Huber, G; Samardzija, M; Seeliger, M; Grimm, C (2011). Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Neurobiology of Disease, 41(1):119-130.
Caprara, C; Thiersch, M; Lange, C; Joly, S; Samardzija, M; Grimm, C (2011). HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Investigative Ophthalmology and Visual Science, 52(5):2109-2117.
Lange, C; Heynen, S R; Tanimoto, N; Thiersch, M; Le, Y Z; Meneau, I; Seeliger, M W; Samardzija, M; Caprara, C; Grimm, C (2011). Normoxic activation of hypoxia-inducible factors in photoreceptors provides transient protection against light-induced retinal degeneration. Investigative Ophthalmology and Visual Science, 52(8):5872-5880.